SamirKGuptaMD

Infectious Disease • Indianapolis, IN

Professor of Medicine; Director, Division of Infectious Diseases, Indiana University School of Medicine

Join to view full profile

Dr. Gupta is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gupta's full profile

Already have an account?

Office
1001 W 10th St
# Opw
Indianapolis, IN 46202
Phone+1 317-630-6263

Education & Training

Indiana University School of MedicineFellowship, Infectious Disease, 2000 - 2003
Indiana University School of MedicineResidency, Internal Medicine, 1996 - 2000
University of Pittsburgh School of MedicineClass of 1996

Certifications & Licensure

IN State Medical License 1997 - 2025
American Board of Internal Medicine Infectious Disease

Clinical Trials

Evaluating the Effectiveness of Pentoxifylline at Improving Blood Vessel Function in HIV-infected People Not Receiving Antiretroviral Medications Start of enrollment: 2009 Jan 01
Completed
Phase 2
Pentoxifylline and Combination Antiretroviral Therapy to Improve Blood Vessel Function in HIV-Infected People Start of enrollment: 2009 Mar 01
Completed
Phase 2
Effects of Etravirine on Endothelial Function in HIV-uninfected Adults: A Pilot Study Start of enrollment: 2009 Apr 01
Completed
Phase 1
Comparing Blood Vessel Endothelial Function in HIV-Infected People and Matched HIV-Uninfected People Start of enrollment: 2009 May 01
Completed
Effects of Switching Efavirenz to Raltegravir on Vascular Function and Bone Markers in HIV-infected Patients Start of enrollment: 2011 Apr 01
Completed
Phase 4
Efavirenz Versus Rilpivirine on Vascular Function, Inflammation, and Oxidative Stress Start of enrollment: 2012 Jul 01
Completed
Phase 4
N-acetylcysteine to Reduce Oxidative Stress and Improve Endothelial Function in HIV-infected Older Adults Start of enrollment: 2013 Oct 01
Completed
Phase 1, Phase 2
Pharmacokinetics of JULUCA in Hemodialysis Start of enrollment: 2021 Apr 23
Completed
Phase 4
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

The steady-state pharmacokinetics of fixed-dose combination dolutegravir+rilpivirine in hemodialysis.
Samir K Gupta, Allon N Friedman, Zeruesenay Desta
AIDS. 2025-03-15
Depressive symptom clusters and biomarkers of monocyte activation, inflammation, and coagulation in people with HIV and depression.
Christopher A Crawford, Brittanny M Polanka, Wei Wu, Krysha L MacDonald, Samir K Gupta
Journal of Health Psychology. 2025-03-01
Remdesivir for Treatment of COVID-19 Requiring Oxygen Support: A Cross-Study Comparison From 2 Large, Open-Label Studies.
Dahlene Fusco, Ivana Malenica, Huldrych F Günthard, Samir K Gupta, Dax Kurbegov
Clinical Infectious Diseases. 2024-11-22

Press Mentions

Indianapolis Hospitals Testing Effects of RemdesivirMay 14th, 2020